Abstract

Human cytomegalovirus (HCMV) is an important pathogen in developing fetuses, neonates, and individuals with compromised immune systems. Gaps in our understanding of the mechanisms required for virion assembly stand in the way of development of antivirals targeting late stages of viral replication. During infection, HCMV causes a dramatic reorganization of the host endosecretory system, leading to the formation of the cytoplasmic virion assembly complex (cVAC), the site of virion assembly. As part of cVAC biogenesis, the composition and behavior of endosecretory organelles change. To gain more comprehensive understanding of the impact HCMV infection has on components of the cellular endocytic recycling compartment (ERC), we used previously published transcriptional and proteomic datasets to predict changes in the directionality of ERC trafficking. We identified infection-associated changes in gene expression that suggest shifts in the balance between endocytic and exocytic recycling pathways, leading to formation of a secretory trap within the cVAC. Conversely, there was a corresponding shift favoring outbound secretory vesicle trafficking, indicating a potential role in virion egress. These observations are consistent with previous studies describing sequestration of signaling molecules, such as IL-6, and the synaptic vesicle-like properties of mature HCMV virions. Our analysis enabled development of a refined model incorporating old and new information related to the behavior of the ERC during HCMV replication. While limited by the paucity of integrated systems-level data, the model provides an informed basis for development of experimentally testable hypotheses related to mechanisms involved in HCMV virion maturation and egress. Information from such experiments will provide a robust roadmap for rational development of novel antivirals for HCMV and related viruses.

Highlights

  • Human cytomegalovirus (HCMV) is a high prevalence viral pathogen capable of causing severe damage and disease in developing fetuses and immunocompromised individuals

  • The initial dataset contained protein abundance data based on liquid chromatography coupled tandem mass spectrometry using HCMV Merlin infected fibroblasts (MOI 10.0) compared to mock-infected cells, at multiple time points, and divided into whole-cell lysate (WCL) and plasma membrane (PM) fractions

  • Despite the public health burden imposed by HCMV, there is a deficiency in the number and target diversity of licensed treatment options

Read more

Summary

Introduction

Human cytomegalovirus (HCMV) is a high prevalence viral pathogen capable of causing severe damage and disease in developing fetuses and immunocompromised individuals. Despite its public health burden, licensed antivirals for HCMV only target viral DNA replication. This lack of antiviral target diversity has contributed to clinical emergence of antiviral-resistant strains. Increased understanding of post-nuclear events during HCMV replication could facilitate identification of druggable targets at the virus–host interface, which can be exploited for the generation of new classes of antivirals. We focus on the cytoplasmic stages of HCMV virion envelopment and egress, with an emphasis on how the virus manipulates the cellular endocytic recycling compartment (ERC) to enable efficient envelopment and egress of nascent virions.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call